
Sign up to save your podcasts
Or
Steve Grzanich has the business news of the day with the Wintrust Business Minute.
Scientists at the University of Illinois-Chicago are working on a new antibiotic that’ll make bacterial resistance nearly impossible. The new antibiotic attacks bacteria is two ways, which makes it 100 million times more difficult for bacteria to develop resistance. That resistance can make it difficult and sometimes impossible to treat infections. Bacterial resistance can sometimes be fatal and it’s considered to be a global health threat. The UIC scientists have been studying a class of synthetic antibiotics called macrolones that interfere with protein production within cells of bacteria and corrupt the structure of its DNA. Because bacteria would have to to fight off both attacks simultaneously, drug resistance would be nearly impossible. UIC researchers worked with Chinese scientists on the antibiotic but more study is needed before it becomes available for human treatment.
Also, Northfield-based Medline Industries may be moving toward an initial public offering. Listen for more below:
4.5
88 ratings
Steve Grzanich has the business news of the day with the Wintrust Business Minute.
Scientists at the University of Illinois-Chicago are working on a new antibiotic that’ll make bacterial resistance nearly impossible. The new antibiotic attacks bacteria is two ways, which makes it 100 million times more difficult for bacteria to develop resistance. That resistance can make it difficult and sometimes impossible to treat infections. Bacterial resistance can sometimes be fatal and it’s considered to be a global health threat. The UIC scientists have been studying a class of synthetic antibiotics called macrolones that interfere with protein production within cells of bacteria and corrupt the structure of its DNA. Because bacteria would have to to fight off both attacks simultaneously, drug resistance would be nearly impossible. UIC researchers worked with Chinese scientists on the antibiotic but more study is needed before it becomes available for human treatment.
Also, Northfield-based Medline Industries may be moving toward an initial public offering. Listen for more below:
1,756 Listeners
5,414 Listeners
38,189 Listeners
497 Listeners
44 Listeners
1,924 Listeners
16 Listeners
1,290 Listeners
431 Listeners
101 Listeners
510 Listeners
1 Listeners
35 Listeners
1,163 Listeners
4 Listeners
10 Listeners
51 Listeners
138 Listeners
360 Listeners
885 Listeners
5,950 Listeners
20 Listeners
45 Listeners
1,546 Listeners
7 Listeners
0 Listeners
1 Listeners
10 Listeners
738 Listeners
4 Listeners
0 Listeners
0 Listeners
286 Listeners
389 Listeners